EPR26-165: Risk Factors for Infection in Chronic Lymphocytic Leukemia: Insights From a Real-World Cohort Treated With Bruton Tyrosine Kinase Inhibitors or Venetoclax

Authors: Divya Samat, Shivam Singh
Publication: Journal of the National Comprehensive Cancer Network
Published: Mar 31, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Assessment of Human Health Risk and Surface Soil Contamination by Some Toxic Elements in Arak City, Iran

Meghdad Bineshpour, Khoshnaz Payandeh et al. - Oct 2121

Read More
Investigating the Non-carcinogenic Risk and Hazard Quotient of Heavy Metals in High-traffic Districts of Tehran Metropolis, Iran

Azam Mahdipour, Mojgan Zaeimdar et al. - Oct 2121

Read More
Investigation and Optimization of Air Pollution Risk by a Multi-criteria Decision Making Method Using Fuzzy TOPSIS: A Case Study of Construction Workers

Eghbal Sekhavati, Reza Jalilzadeh Yengejeh - Oct 2121

Read More
Organizational Factors Associated With Nurses’ Competence in Averting Failure to Rescue in Acute Care Settings

Asonye Christian Chinedu Chichi - Feb 2121

Read More
Factors affecting “resistance to change”: an explanatory study conducted in the healthcare sector

Vasiliki Amarantou, Stella Kazakopoulou et al. - Jan 2117

Read More